Beyond Air, Inc. cash flow statement
In fiscal 2026, Beyond Air, Inc.'s operations generated −$18.1m of cash; it spent $1.0m on capital projects, leaving free cash flow of −$19.2m.
Cash flow statement
| Fiscal year | 2019Mar 2019 | 2020Mar 2020 | 2021Mar 2021 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 1 | −15 | −20 | −56 | −38 | −18 | −19 |
| Depreciation and amortisation | 0 | 0 | 0 | 2 | 3 | 3 | 3 |
| Stock-based pay | 2 | 4 | 5 | 21 | 9 | 5 | 5 |
| Capital spending | 0 | 0 | 1 | 6 | 6 | 1 | 1 |
| Free cash flow | 1 | −15 | −21 | −62 | −44 | −19 | −20 |
| Free cash flow after stock pay | −1 | −19 | −25 | −83 | −53 | −24 | −24 |
| Shares issued | 1 | — | 50 | — | 19 | 5 | — |
| Quarter | 2025 Q2Sept 2024 | 2025 Q3Dec 2024 | 2025 Q4Mar 2025 | 2026 Q1Jun 2025 | 2026 Q2Sept 2025 | 2026 Q3Dec 2025 | 2026 Q4Mar 2026 | 2027 Q1Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −13 | −8 | −7 | −5 | −4 | −4 | −5 | −5 |
| Depreciation and amortisation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Stock-based pay | 3 | 2 | 0 | 2 | 2 | 2 | 0 | 1 |
| Capital spending | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 |
| Free cash flow | −15 | −8 | −8 | −5 | −5 | −4 | −5 | −5 |
| Free cash flow after stock pay | −18 | −11 | −9 | −6 | −6 | −6 | −6 | −6 |
| Shares issued | — | 0 | 0 | — | — | — | 4 | — |
Compare with peers
- Invo Fertility, Inc. cash flow
- Anbio Biotechnology cash flow
- Nuwellis, Inc. cash flow
- Milestone Scientific Inc. cash flow
- Neuroone Medical Technologies Corp cash flow
Head to head: IVF vs XAIRNNNN vs XAIRNUWE vs XAIR
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies